Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Combination of IGF-IR and RAF/MEK/Erk inhibitors may improve the efficacy in cancer therapy
The result is a dramatically extended half-life and increased bioavailability, making it the gold standard for research in cellular proliferation, muscle hypertrophy, and metabolic signaling
GnRH antagonists with or without Add-Back therapy: A new alternative in the management of endometriosis
GHK-Cu and Cellular Senescence: Downstream Oxidative Mechanism In aged fibroblasts identified by high SA--gal activity, GHK-Cu reduces SA--gal+ cells from 48% to 28% (41%), p16INK4a mRNA 2832%, and p21WAF1 2226% with 7-day treatment indicating partial reversal of the senescent phenotype
Targeting CYP51A1: small-Molecule inhibitors and therapeutic potential The cholesterol biosynthetic pathway has proven to be a successful target in drug development, as exemplified by statins for hypercholesterolemia and azole antifungals for infectious diseases [97, 98]
Biochimie 86 , 839848 (2004)
US$ 29.81
US$ 27.06
US$ 29.20
US$ 25.10
